Umbilical Cord Blood Stem Cells: Developing Allogeneic Therapies by MEDIPOST Co., Ltd.
Charles River Laboratories and MEDIPOST have entered a non-exclusive Memorandum of Understanding (MOU) to standardize Excellent Manufacturing Practice (GMP) protocols for allogeneic, umbilical cord blood-derived mesenchymal stem/stromal cells. This partnership ... Read More